The rostral interstitial nucleus of the medial longitudinal fascicle (riMLF) contains premotor neurons essential for the generation of rapid vertical eye movements. The Alzheimer's disease (AD)-related cytoskeletal changes and b-amyloid deposits in this nucleus were examined in 30 autopsy cases and compared to the involvement of three associated nuclei -Edinger-Westphal nucleus, nucleus of Darkschewitsch and interstitial nucleus of Cajal. The riMLF displays slight cytoskeletal alterations already in the early stages in the development of the cortical cytoskeletal pathology (cortical NFT/NT-stages I -II, representing the preclinical phase of AD). In the cortical NFT/NT-stages III-IV (i.e. incipient phase of AD), the cytoskeletal pathology in the riMLF is pronounced and in stages V-VI (i.e. clinical phase of AD) it is severe. The progression of the cytoskeletal pathology in the riMLF correlates significantly with the cortical NFT/NT-stages I -VI that reflect the clinical course of AD. Isolated b-amyloid deposits appear in the riMLF for the first time in the final b-amyloid stage. In the Edinger-Westphal nucleus, in the nucleus of Darkschewitsch and most markedly in the interstitial nucleus of Cajal, the pathological changes were significantly less severe than those in the riMLF. In the event that the cytoskeletal pathology impairs the function of the premotor neurons of the riMLF, one would predict a progressive slowing of vertical saccades corresponding to the advancing cortical NFT/NT-stages.
Introduction
Vertical saccades are triggered by high frequency discharges on the part of premotor burst neurons, shown by experimental and clinical studies to reside in the rostral interstitial nucleus of the medial longitudinal fascicle (riMLF) (Bü ttner-Ennever, Bü ttner, Cohen, & Baumgartner, 1982; Leigh & Zee, 1991 Horn, Bü ttner-Ennever, Suzuki, & Henn, 1995; Horn & Büt-tner-Ennever, 1998; Horn, Bü ttner, & Bü ttner-Ennever, 1999) . The premotor burst neurons of the riMLF receive afferents from the ventral layers of the superior colliculus and project to the motoneuron pools of the oculomotor and trochlear nuclei that innervate the vertical-pulling eye muscles ( Figs. 1 and 2a) . The slowing of the vertical saccades usually indicates a malfunction in burst cells of the riMLF. Likewise, the neighboring interstitial nucleus of Cajal (iC) contributes to vertical saccades (Figs. 1 and 2b) , but is more involved in the integration of eye-velocity into eye-position signals (Leigh & Zee, 1991 Horn et al., 1995 Horn et al., , 1999 Horn & Bü ttner-Ennever, 1998) .
Severe impairments of memory, disorientation with regard to time and place, impaired judgment, lexical dysfunctions, apraxia, agnosia, and changes in personality and behavior are among the most striking clinical symptoms of Alzheimer's disease (AD) (Schofield & Mayeux, 1998) , whereas overt neurological deficits of vertical saccades have been detected only occasionally in patients suffering from AD (Daffner, Scinto, tin, Crain, Sisodia, & Troncoso, 1998) and, initially, they appear as a non-argyrophilic material in the perikarya and dendrites of affected neurons (Goedert, 1993; Braak et al., 1994; Kosik & Greenberg, 1994; Goedert, Jakes, & Vanmechelen, 1995; Price et al., 1998) . The gradual amassing of this material leads to the formation of the solid and, in time, argyrophilic neurofibrillary material appear as neurofibrillary tangles (NFTs) in perikarya and as neuropil threads (NTs) in dendrites (Gallyas, 1971; Braak & Braak, 1991a; Goedert, 1993; Braak et al., 1994; Price et al., 1998) . The extracellular deposits consist of insoluble fibrils containing the protein b-amyloid and occur in a wide array of plaque types within the neuropil as well as in the walls of cerebral blood vessels (Probst et al., 1991; Price et al., 1998; Thal, Rü b, Schultz, Sassin, Ghebremedhin, Del Tredici, Braak, & Braak, 2000) .
The present study aims at drawing the attention of vision researchers and clinicians to the progressive involvement of the riMLF during the development of the AD-related cytoskeletal pathology.
Materials and methods
The brains of 30 individuals (16 females, mean age 81.596.7 years; 14 males, mean age 78.99 9.1 years) obtained at autopsy were classified according to a staging procedure permitting differentiation between six stages in the development of the AD-related neurofibrillary pathology within the cerebral cortex (cortical NFT/NT-stages I-VI) and between three stages in the intracerebral evolution of b-amyloid deposition (b-amyloid stages A-C) (Braak & Braak, 1991b , 1997a (Table   Weintraub, Guinenessy, & Mesulam, 1992) . Accordingly, it was with some surprise that our brain material showed evidence of significant damage to the nerve cells of the riMLF in the form of AD-related cytoskeletal pathology.
The pathological changes that gradually develop in the course of AD are based on intraneuronal and extraneuronal deposits of abnormal proteins. The intraneuronal deposits originate subsequent to the abnormal phosphorylation of the cytoskeletal protein t (Probst, Langui, & Ulrich, 1991; Goedert, 1993; Braak, Braak, & Mandelkow, 1994; Price, Thinakaran, Borchelt, Mar- Table 1 Case number (C), age (A), gender (G) and neuropathological classification of the cases examined. All cases were classified according to an established staging system to the severity and distribution of the AD-related cortical neurofibrillary pathology (N: cortical NFT/NT-stages I-VI), as well as intracerebral b-amyloid deposits (AM: b-amyloid stages A-C) (Braak & Braak, 1991b; Braak & Braak, 1997a) 
a The columns 6-8 supply the severity (0 = no lesions; 1 = mild: 1-5 lesions; 2 = marked: 6-25 lesions; 3 =severe: more than 25 lesions; n.d.=not determined) of the neurofibrillary pathology (NF), AT8-immunopositive cytoskeletal pathology (AT8), and b-amyloidosis (bA) in the rostral interstitial nucleus of the medial longitudinal fascicle (riMLF). For comparative purposes, the severity of the respective changes in the Edinger-Westphal nucleus (EW) is shown in columns 9-11, that of the nucleus of Darkschewitsch (nD) in columns 12-14, and that of the interstitial nucleus of Cajal (iC) in columns 15-17. 1). All of the brains were fixed by immersion in a 4% aqueous solution of formaldehyde. Thereafter, they were dehydrated, embedded in polyethylene glycol (PEG 1000, Merck) and cut into an uninterrupted series of 100-mm frontal sections (Smithson, MacVicar, & Hatton, 1983; Braak & Braak, 1991b) .
A serial collection consisting of the 1st, 11th, 21st etc. equidistant sections stained both for Nissl material (Darrow red) and lipofuscin pigmentation (aldehydefuchsin) (Braak, 1980; Braak & Braak, 1991b) served as a means of topographical orientation. A serial collection of the 2nd, 12th, 22nd etc. equidistant sections was then stained with a modified silver-iodide Gallyas technique for detection of AD-related neurofibrillary changes (Gallyas, 1971; Braak & Braak, 1991a) , whereas the 3rd serial collection underwent staining with the modified Campbell-Switzer silver-pyridine method to highlight the AD-related b-amyloid deposits (Campbell, Switzer, & Martin, 1987; Braak & Braak, 1991a) . In 25 cases, a 4th serial collection was used to assess reactions between the abnormally phosphorylated t protein and the monoclonal antibody AT8, which does not cross-react with normal t epitopes (Innogenetics, Ghent, Belgium) (Mercken, Vandermeeren, Lü bke, Six, Boons, Van de Voorde, Martin, & Gheuens, 1992; Braak et al., 1994; Goedert et al., 1995) . The free-floating sections were incubated for 40 h at 4°C (antibody dilution 1:2000). Following processing with the second biotinylated antibody (anti-mouse IgG, 2 h), immunoreactions were visualized by means of the ABC complex (Vectastain) and 3,3-diaminobenzidinetetra-HCl/H 2 O 2 (DAB, D5637 Sigma). In 15 of the cases (two cases at cortical NFT/NT-stages I-V and five cases at stage V), a further collection of sections was immunostained, as described above with the exception of a higher dilution of the AT8 antibody (1:3000). This last set of sections was counterstained for lipofuscin deposits and Nissl material to confirm the location of the immunopositive material. All of the sections were cleared and mounted in a synthetic resin (Permount Fisher).
In addition to an average of three equidistant sections through the riMLF treated with the silver-iodide Gallyas technique or by the modified CampbellSwitzer silver-pyridine method, an average of three equidistant sections through the riMLF processed with the antibody AT8 were examined per case. The severity of the AD-related alterations was assessed by counting the number of AT8-immunopositive perikarya, NFT/ NTs and b-amyloid deposits per section using the following scale: no lesions=0; one to five lesions (mild) = 1; six to 25 lesions (marked)= 2; more than 25 lesions (severe)= 3. Counting was performed at a final magnification of 10:1 and blind to the results of the classification of the AD-related cortical pathology. In each of the cases, the severity of the abnormal alterations in the riMLF was compared to the extent of the pathological changes in adjacent nuclei: Edinger-Westphal, nucleus of Darkschewitsch, interstitial nucleus of Cajal.
The one-way analysis of variance, according to Kruskal and Wallis (H-test), was used to determine the degree to which the nuclei-specific AD-related cytoskeletal pathology is dependent upon the stages I-VI. Our working hypothesis that the severity of the pathology in the four nuclei gradually increases with the increasing severity of cortical neurofibrillary pathology was tested by means of a non-parametric trend analysis. The correlation between the severity of the pathology seen in Gallyas silver stained sections and that seen in immunoreactions was described using Kendall's rank correlation coefficient tau (t) (Bortz, Lienert, & Boehnke, 1990) .
Results

Anatomical remarks
The rostral interstitial nucleus of the medial longitudinal fascicle nucleus (riMLF) is situated dorsomedial to the red nucleus and ventral to the thalamus (Fig. 2a) . Dorsally, it is bordered by the thalamo-subthalamic paramedian artery (Bü ttner-Ennever et al., 1982; Leigh & Zee, 1991; Horn & Bü ttner-Ennever, 1998; Horn et al., 1999) . In frontal sections, the riMLF appears as a wing-shaped nucleus in close proximity to the medially situated central gray and to the dorsally located subparafascicular nucleus of the thalamic central complex (Fig. 2a) Horn et al., 1999) . The nerve cells of the riMLF are loosely scattered among the fiber bundles of the rostral portions of the medial longitudinal fascicle (MLF).
The tractus retroflexus separates the riMLF from the caudally located interstitial nucleus of Cajal (iC), which likewise lies within the MLF and is situated laterally to the Edinger-Westphal nucleus (Fig. 2b) Olszewski & Baxter, 1982; Horn & Bü ttner-Ennever, 1998; Horn et al., 1999) . The iC is bordered dorsally by the nucleus of Darkschewitsch (nD), which forms an indentation on the ventral border of the central gray (Fig. 2b) Olszewski & Baxter, 1982; Leigh & Zee, 1991; Horn & Bü ttner-Ennever, 1998; Horn et al., 1999) . The Edinger-Westphal nucleus (EW) is located medially to the iC (Fig. 2b) and abuts ventrally on the rostral oculomotor nucleus (Olszewski & Baxter, 1982; Leigh & Zee, 1991) .
The AD-related cytoskeletal pathology in the riMLF and associated nuclei
The development of the AD-related immunoreactive cytoskeletal changes in the riMLF is already detectable when NFT/NT-stage I pathology is found in the cerebral cortex and is linearly linked to the progress of the NFT/NT-stages I-VI within the cortex (Tables 1 and  2 ). The sections immunostained with the antibody AT8 and counterstained for lipofuscin deposits and Nissl material reveal that the large, elongated and presumably premotor neurons oriented with their long axes parallel to the mediolateral axis of the riMLF (Horn & Bü ttner-Ennever, 1998 ) are the preferential targets of these changes (Fig. 3a) .
At cortical stages I-II, alongside several thin AT8-immunoreactive dendrites, a few AT8-immunopositive somata occur in the medial portions of the riMLF (Table 1 ; Fig. 3a) . In cases at NFT/NT-stages III-IV, the riMLF shows numerous immunoreactive dendrites and nerve cell somata located predominantly in the medial aspects of the riMLF (Fig. 3b) . In stages V-VI, the AT8-immunoreactive cytoskeletal pathology in the riMLF is at its peak (Table 1) , with numerous immunopositive perikarya surrounded by a weave of short or long immunoreactive dendrites (Fig. 3(c) and Fig.  4a) .
The AD-related NFT/NTs in the riMLF occur with regularity for the first time at the cortical NFT/NTstage IV (Table 1 ). The severity of the neurofibrillary changes in the riMLF at stages IV-VI is routinely less than that of the AT8-immunopositive cytoskeletal pathology observable there (Table 1) . Nevertheless, it increases linearly with the growing severity of the immunoreactive lesions and this in correlation with concurrent cortical NFT/NT-stages I-VI ( Table 2) .
As in the riMLF, the severity of the AT8-immunopositive cytoskeletal pathology in the EW, nD and iC corresponds to that of the cortical NFT/NTstages I-VI (Tables 1 and 2 ). In addition, in all three nuclei, the increasing gravity of the AT8-immunoreactive lesions correlates with that of the AD-related neurofibrillary changes and, again, is linked linearly to the progression of stages I-VI (Table 2) .
The EW, like the riMLF, consistently exhibits AT8-immunopositive neurons up to NFT/NT-stages I-II (Table 1) and routinely shows the first neurofibrillary changes at stage IV (Table 1) . At stages IV-VI, however, the EW is less severely involved in the AT8-immunoreactive cytoskeletal pathology than the riMLF (Table 1; Fig. 4b ). Furthermore, in the majority of cases at cortical NFT/NT-stages V-VI, fewer NFT/ NTs are encountered in the EW than in the riMLF (Table 1) .
The first AT8-immunopositive cytoskeletal alterations appear with regularity in the nD at cortical NFT/NT stage III and neurofibrillary tangles occur riMLF, rostral interstitial nucleus of the medial longitudinal fascicle; EW, Edinger-Westphal nucleus; nD, nucleus of Darkschewitsch; iC, interstitial nucleus of Cajal): line 1, value of the test statistic H corr of the one-way analysis of variance for the AT8-immunopositive nerve cell somata and nerve cell processes; line 2, significance level of the value of the test statistic H corr of line 1; line 3, value of the test statistic H lin from the trend analyses for the AT8-immunopositive nerve cell somata and nerve cell processes; line 4, significance level of the value of the test statistic H lin of line 3; line 5, value of the test statistic H corr of the one-way analysis of variance for the NFT/NT; line 6 -significance level of the value of the test statistic H corr of line 5; line 7, value of the test statistic H lin from the trend analyses for the NFT/NT; line 8, signifcance level of the value of the test statistic H lin of line 7; line 9, value of Kendalls rank correlation tau between the severity of the AT8-immunopositive cytsoskeletal pathology and the severity of the AD-related neurofibrillary pathology; line 10, significance level of the test statistic t according to Kendall. there consistently up to stage V (Table 1) . In cases at stages V-VI, the nD displays a marked, but less developed immunoreactive cytoskeletal pathology than the riMLF (Table 1; Fig. 4c) . Moreover, the nD of most of the cases at stages V-VI exhibits a lower number of NFT/NTs when compared with the riMLF (Table 1) .
In the final two cortical NFT/NT-stages V-VI, some isolated AT8-immunoreactive neurons are routinely demonstrable in the iC as well (Table 1; Fig. 4c ). AD-related NFT/NTs, however, occur in this nucleus only inconstantly at these stages (Table 1) .
Deposits of i-amyloid in the riMLF and associated nuclei
Some isolated AD-related b-amyloid deposits consistently develop in the riMLF and the nD in the final stage of b-amyloidosis (stage C) ( Table 1 ). The lesions present as relatively small, irregularly outlined, dark plaque-like deposits. Even in stage C, there are very few b-amyloid deposits in the iC and EW (Table 1) .
Discussion
The riMLF is regularly a target of both the AD-related cytoskeletal pathology and b-amyloidosis, although the alterations there appear 'prima vista' somewhat unimpressive. In view of the riMLF's low nerve cell density, however, and compared with the extent of the lesions in the EW, nD and iC, the cytoskeletal pathology in the riMLF is remarkably severe.
An earlier study conducted on the rostral midbrain entailing thin sections of brain tissue and conventional staining techniques failed to detect the involvement of the riMLF in AD (Hunter, 1985) . The fact that we managed to demonstrate for the first time the existence of the AD-related cytoskeletal pathology in the riMLF underscores the advantage of immunocytochemical or advanced silver staining methods when it comes to identifying the location of the less prominent AD-related lesions, particularly when such methods are applied to relatively thick tissue sections. The superiority of thick tissue sections over paraffin sections results from the optical superposition of biological structures (Braak & Braak, 1991a; Heinsen & Heinsen, 1991) .
The AD-related changes appear preferentially in the large-sized and elongated nerve cells of the riMLF that are involved in the generation of vertical saccades (Horn & Bü ttner-Ennever, 1998; Horn et al., 1999) . The cytoskeletal alterations in these neurons presumably exert a detrimental influence on their function, thereby drawing attention to themselves via a reduction of the maximal velocity of vertical saccades. Conceivably, the severity of the pathology in the riMLF suffices to cause Table 1 ). a slowing of vertical saccades, whereby a certain threshold is required before disorders of these rapid eye movements can be detected without the aid of electrophysiological devices.
According to some sources, slowing of vertical (predominantly upward) saccades is regarded as a phenomenon of normal aging (Hotson & Steinke, 1988) . Ongoing post-mortem studies of so-called 'normally' aging individuals between 60 and 80 years of age can assign 70% of the cases to cortical NFT/NT-stages I-II (i.e. preclinical phase of AD) and 20% to cortical NFT/NT-stages III-IV (i.e. incipient phase of AD) (Braak & Braak, 1991b , 1997a Schofield & Mayeux, 1998) . Given the fact that at cortical NFT/NT stages I-IV the riMLF is consistently involved in the AD-related cytoskeletal pathology, it remains to be seen whether the abnormal changes in this nucleus account for the slowing of vertical saccades associated with normal aging, as demonstrated in some oculographic studies (Hotson & Steinke, 1988) .
By way of its protectal afferents and its projections to the nerve cells of the ciliary ganglion, the cholinergic neurons of the EW adjust the width of the pupil (Bü ttner-Ennever, Cohen, Horn, & Reisine, 1996) . Several studies have demonstrated that persons suffering from AD exhibit a hypersensitive pupillary response to the cholinergic antagonist tropicamide (Scinto, Daffner, Dressler, Ransil, Rentz, Weintraub, Mesulam, & Potter, 1994; Gomez-Tortoza, del Barrio, & Jimenez-Alfaro, 1996; Kurz, Marquand, Fremke, & Leipert, 1997) . Similar to Hunter, Scinto et al. observed cytoskeletal alterations in the EW of individuals clinically diagnosed as having AD and explained this hypersensitivity pupillary response by means of the lesions in the EW (Hunter, 1985; Scinto, Wu, Firla, Daffner, Saroff, & Geula, 1999) . Inasmuch as Scinto et al. found these alterations in the EW of three clinically silent cases that showed AD-related cortical cytoskeletal changes as well (Scinto et al., 1999) , they speculated that the involvement of the EW might be an early event in the evolution of the AD-related cytoskeletal pathology. Our study performed on staged brain material confirms their conjecture that the EW is among the early targets of the cytoskeletal changes.
There is an acknowledged need for clinical signs capable of serving as early diagnostic markers for AD and, at the same time, as parameters for monitoring the clinical progression as well as effects of therapy (Almkvist & Winblad, 1999) . Since the EW appeared to become involved early on in the course of AD, Scinto et al. hypothesized that a hypersensitive pupillary response could function as an early marker for the disease process (Scinto et al., 1999) . Although the EW, similar to riMLF, is affected by the AD-associated cytoskeletal pathology already in the cortical NFT/NTstages I-II (the preclinical phase), the degree of the EW involvement at cortical NFT/NT-stages III-IV (the incipient phase) is less severe than the degree of pathology in the riMLF. Thus, we have reached the conclusion that future clinical studies devoted to improving the diagnosis of AD should re-double their efforts in assessing vertical saccadic performance.
In closing, the progression of the cytoskeletal pathology in the riMLF correlates closely with the cortical NFT/NT-stages I-VI, thereby reflecting the clinical course of AD (Bancher, Braak, Fischer, & Jellinger, 1993; Braak & Braak, 1991b , 1997a . Against the background of this correlation, the following trajectory emerges: a progressive slowing of vertical saccades occurs, which extends from the preclinical phase beyond the incipient phase well into the clinical end-stages of AD. In view of the pressing need for improved diagnostic parameters and given the developmental pattern of the AD-related cytoskeletal changes observable in the riMLF, additional oculographic studies are called for to verify our hypothesis here that clinical evaluation of vertical saccades could be implemented one day as an index both (1) for identifying AD patients while they are still in the preclinical or incipient phases of the disorder and, eventually, (2) for monitoring the course of the disease and ongoing patient response to drug regimens.
